New light scanner could replace liver biopsies for transplant patients
NCT ID NCT07254533
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a near-infrared spectroscopy device that scans the liver with light to diagnose and measure fatty liver disease. Researchers aim to see if it can accurately detect fat levels above 5% and 30%, which are important for liver transplant decisions. The study will include 90 liver grafts and surgical samples from adults. If it works, this non-invasive tool could replace the current biopsy method, which is invasive and can vary between doctors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- near-infrared spectrometer
- What this could lead to
- If successful, this could provide a quick, non-invasive way to measure liver fat, helping doctors decide which donor livers are safe to transplant.
- What could go wrong
- This is an early-stage study with only 90 participants, and the device may not be accurate enough to replace current biopsy methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Timone Hospital
Marseille, 13005, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.